Cargando…

Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan

BACKGROUND: This study used a large-scale cancer database in determination of prognostic factors for the survival of lung cancer subjects in Taiwan. METHODS: Total of 24,910 subjects diagnosed with lung cancer was analysed. Survival estimates by Kaplan-Meier methods. Cox proportional-hazards model e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Tai-An, Chen, Ping-Ho, Wu, Pei-Fen, Wang, Tsu-Nai, Chang, Po-Ya, Ko, Albert Min-Shan, Huang, Ming-Shyan, Ko, Ying-Chin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2587478/
https://www.ncbi.nlm.nih.gov/pubmed/18992131
http://dx.doi.org/10.1186/1471-2407-8-324
Descripción
Sumario:BACKGROUND: This study used a large-scale cancer database in determination of prognostic factors for the survival of lung cancer subjects in Taiwan. METHODS: Total of 24,910 subjects diagnosed with lung cancer was analysed. Survival estimates by Kaplan-Meier methods. Cox proportional-hazards model estimated the death risk (hazard ratio (HR)) for various prognostic factors. RESULTS: The prognostic indicators associated with a higher risk of lung cancer deaths are male gender (males versus females; HR = 1.07, 95% confidence intervals (CI): 1.03–1.11), males diagnosed in later periods (shown in 1991–1994 versus 1987–1990; HR = 1.13), older age at diagnosis, large cell carcinoma (LCC)/small cell carcinoma (SCC), and supportive care therapy over chemotherapy. The overall 5-year survival rate for lung cancer death was significantly poorer for males (21.3%) than females (23.6%). Subjects with squamous cell carcinoma (SQCC) and treatment by surgical resection alone had better prognosis. We find surgical resections to markedly increase 5-year survival rate from LCC, decreased risk of death from LCC, and no improved survival from SCC. CONCLUSION: Gender and clinical characteristics (i.e. diagnostic period, diagnostic age, histological type and treatment modality) play important roles in determining lung cancer survival.